InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by KIIL HARRY SKIP. Director active across 1 company, notably Medtronic plc. Cumulatively, 5 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €660k. History available since 28 July 2025. The latest transaction was disclosed on 19 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
KIIL HARRY SKIP is a declarant linked to Medtronic plc, where he is EVP & President Cardiovascular. He has 5 filings in total, and the sampled recent filings cover the period from 2025-07-30 to 2026-02-26, with 0 in buys and 660120 in sells; the most frequent transaction nature shown is Option exercise.